{
    "Trade/Device Name(s)": [
        "25-OH Vitamin D EIA Kit",
        "25-OH Vitamin D EIA Control Kit"
    ],
    "Submitter Information": "Diazyme Laboratories",
    "510(k) Number": "k122420",
    "Predicate Device Reference 510(k) Number(s)": [
        "k021163"
    ],
    "Regulatory Class": "Class II (Assay); Class I (Control)",
    "Product Code(s)": [
        "MRG",
        "JJX"
    ],
    "Summary Letter Date": "November 28, 2012",
    "Summary Letter Received Date": "October 18, 2012",
    "Submission Date": "October 16, 2012",
    "Regulation Number(s)": [
        "21 CFR 862.1825",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Vitamin D Test System",
        "Quality Control Material (Assayed and Unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "25-OH Vitamin D",
        "25-OH Vitamin D2",
        "25-OH Vitamin D3"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "K3-EDTA tube",
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Microplate reader"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)",
        "Colorimetric detection"
    ],
    "Methodologies": [
        "Competitive binding immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Diazyme 25-OH Vitamin D EIA Kit and Control Kit for quantification of total 25-OH Vitamin D in serum and plasma using enzyme immunoassay.",
    "Indications for Use Summary": "Designed for quantification of total 25-OH Vitamin D in human serum and plasma; results are used with other clinical data to assess vitamin D status; control kit for quality control with the assay.",
    "fda_folder": "Clinical Chemistry"
}